HAS IL2 A ROLE IN THE MANAGEMENT OF MINIMAL RESIDUAL DISEASE FOR ACUTE-LEUKEMIA

被引：0

作者：

FOA, R ^{[1
]}

MELONI, G ^{[1
]}

GUARINI, A ^{[1
]}

MANDELLI, F ^{[1
]}

GAVOSTO, F ^{[1
]}

机构：

[1] UNIV ROME, DIPARTIMENTO BIOPATOL UMANA, SEZIONE EMATOL, I-00100 ROME, ITALY

来源：

LEUKEMIA | 1992年 / 6卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Based on pre-clinical findings and on more recent preliminary in vivo data it has been suggested that immunotherapy with Interleukin 2 (IL2) may be employed in the treatment of acute leukemia patients. Here we shall discuss the biological and clinical observations which indicate that this innovative therapeutic approach may play a role in the management of minimal residual disease.

引用

页码：92 / 94

页数：3

共 50 条

[21] Minimal residual disease in acute leukemia
Boissel, Nicolas
HEMATOLOGIE, 2020, 26 : 3 - 4
[22] Role of minimal residual disease in the management of acute myeloid leukemia—a case-based discussion
A. Coltoff
J. Houldsworth
A. Keyzner
A. S. Renteria
John Mascarenhas
Annals of Hematology, 2018, 97 : 1155 - 1167
[23] DIAZIQUONE HAS A LIMITED ROLE IN THE TREATMENT OF ACUTE-LEUKEMIA
ARLIN, Z
FELDMAN, E
BUDMAN, D
STASZEWSKI, H
BIGUZZI, S
SCHULMAN, P
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 212 - 212
[24] Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease
Maurillo, Luca
Bassan, Renato
Cascavilla, Nicola
Ciceri, Fabio
CANCERS, 2019, 11 (10)
[25] FLOW CYTOMETRIC DETERMINATION OF ATYPICAL ANTIGEN EXPRESSION IN ACUTE-LEUKEMIA FOR THE STUDY OF MINIMAL RESIDUAL DISEASE
DRACH, J
DRACH, D
GLASSL, H
GATTRINGER, C
HUBER, H
CYTOMETRY, 1992, 13 (08): : 893 - 901
[26] POLYMERASE CHAIN-REACTION (PCR) APPROACH FOR THE EVALUATION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA
BIONDI, A
RAMBALDI, A
STEM CELLS, 1994, 12 (04) : 394 - 401
[27] Role of minimal residual disease in the management of acute myeloid leukaemias
Preudhomme, Claude
HEMATOLOGIE, 2019, 25 : 3 - 16
[28] MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - EXPECTATIONS, POSSIBILITIES AND INITIAL CLINICAL-RESULTS
CAMPANA, D
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1994, 24 (03): : 132 - 138
[29] THROMBOCYTOPENIA IN ACUTE-LEUKEMIA PATIENTS TREATED WITH IL2 - CYTOLYTIC EFFECT OF LAK CELLS ON MEGAKARYOCYTIC PROGENITORS
GUARINI, A
SANAVIO, F
NOVARINO, A
TOS, AG
AGLIETTA, M
FOA, R
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (03) : 451 - 456
[30] DNA FINGERPRINTING IN THE DETECTION OF RESIDUAL DISEASE IN ACUTE-LEUKEMIA
PAKKALA, S
LEUKEMIA, 1991, 5 (05) : 437 - 440

← 1 2 3 4 5 →